Session

Sessions

Bayer: What is Bayer’s vision for the future of ophthalmology?

Sessions

Bayer: Is sustained disease control the new benchmark for patient care?

Sessions

Bayer: Have we maximised patient outcomes, or can we go further?

Sessions

Lumibird: Laser for retina and vitreous: All you need to know in 2023

Sessions

IME: Dry AMD & GA IME Platform: Practical Considerations for GA Treatment

Sessions

Roche: Retinale® – EURETINA Kompakt

Sessions

Roche: Discovering ChANGe with Ang-2

Sessions

Roche: The future of continuous drug delivery for retinal diseases

Sessions

Roche: Change in treatment paradigm for DME with faricimab: Evidence from clinical trials and real-world practice

Sessions

Optos: Advances in Ultra-widefield Multimodal Retinal Imaging – Learn from our Experts

Sessions

Bausch & Lomb: New Dimensions in Visualization: Changing the Way You Look

Sessions

Heidelberg: High-Resolution OCT in Retinal Disorders including atrophic AMD

Sessions

Lumithera: LIGHTSITE III Pivotal Trial 24-Month Analysis: Multiwavelength Valeda® Light Delivery System Treatment in Early/Intermediate Dry Age-Related Macular Degeneration Patients

Sessions

Apellis: Geographic Atrophy: Navigating to the future

Sessions

Zeiss: Informed decision-making every step of the way – Part 2: Visualization in vitreoretinal surgery

Secretariat Address
European Society of Retina Specialists
Ground Floor, The Apex Building
Blackthorn Road
Sandyford Business Park
Co Dublin, D18 H6K2

Phone:+353 1 2100092
Email: [email protected]

EURETINA 2023 Amsterdam

EURETINA Innovation Spotlight (EIS)

Abstract Viewer

Ophthalmologica

Opportunities

Memberships

Privacy Policy

Newsletter Sign up

Follow us

© EURETINA 2022 All rights reserved